References

• Aamir, A. H. et al. (2019) 'Diabetes Prevalence Survey of Pakistan (DPS-PAK): Prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: A popula#on-based survey from Pakistan', BMJ Open, 9(2), pp. 1-9. DOI: 10.1136/bmjopen-2018-025300.
• Adnan, M. & Aasim, M. (2020) 'Prevalence of type 2 diabetes mellitus in adult popula#on of Pakistan: A meta-analysis of prospec#ve cross-sec#onal surveys', Annals of Global Heal!, 86(1), pp. 1-8. DOI: 10.5334/aogh.2679.
• Aref, A. et al. (2019) 'Pancrea#c transplanta#on: Brief review of !e current evidence', World Journal of Transplanta#on, 9(4), pp. 81-93. DOI: 10.5500/wjt.v9.i4.81.
• Aroda, V. R. & Ratner, R. E. (2018) 'Metformin and type 2 diabetes preven#on, Diabetes Spectrum, 31(4), pp. 336-342. DOI: 10.2337/ds18-0020.
• Benjamin, B. K. et al. (2021) 'The Associa#on between Type-2 Diabetes Dura#on and Major Adverse Cardiac Events after Percutaneous Coronary Interven#on', 2021.
• Bisson, A. et al. (2021) 'Sex, age, type of diabetes and incidence of atrial fibrilla#on in pa#ents wi! diabetes mellitus: a na#onwide analysis', Cardiovascular Diabetology. BioMed Central, 20(1), pp. 1-11. DOI: 10.1186/s12933-021-01216-7.
• Buras, E. D. et al. (2019) ‘Fibro-adipogenic remodeling of !e diaphragm in obesity - associated respiratory dysfunc#on', diabetes, 68(1), pp. 45-56. DOI: 10.2337/db18-0209.
• Care, D. & Suppl, S. S. (2021a) '2. Classifica#on and Diagnosis of Diabetes : .andards of Medical Care in Diabetes d 2021', 44(January), pp. 15-33. DOI: 10.2337/dc21-S002.
• Care, D. & Suppl, S. S. (2021b) 'Pharmacologic approa'es to glycemic treatment: .andards of medical care in diabetesd2021', Diabetes Care, 44(January), pp. S111-S124. DOI: 10.2337/dc21-S009.
• Das, S. et al. (2020) 'Since January 2020 Elsevier has created a COVID-19 resource center wi! free informa#on in English and Mandarin on !e novel coronavirus COVID - 19. The COVID-19 resource center is hosted on Elsevier Connect, !e company's public news and informa#on ', (January).
• Da(a, B. K., Husain, M. J. & Asma, S. (2019) 'Assessing !e rela#onship between out - of-poet spending on bl*d pressure and diabetes medica#on and household catastrophic heal! expenditure: Evidence from Pakistan', Interna#onal Journal for Equity in Heal!. Interna#onal Journal for Equity in Heal!, 18(1), pp. 1-12. DOI: 10.1186/s12939-018-0906-x.
• Forbes, J. M. & Fo!eringham, A. K. (2017) ‘Vascular complica#ons in diabetes: old messages, new !oughts', Diabetologia. Diabetologia, 60(11), pp. 2129-2138. DOI: 10.1007/s00125-017-4360-x.
• Gillani, A. H. et al. (2018) 'Direct and indirect cost of diabetes care among pa#ents wi! type 2 diabetes in private clinics: a mul#center study in Punjab, Pakistan', Expe) Review of Pharmacoeconomics and Outcomes Resear'. Taylor and Francis Ltd, 18(6), pp. 647-653. DOI:10.1080/14737167.2018. 1503953.
• Grujić, M. & Petronijević-Novak, S. (1988) ‘[Dental and oral aspects of diabetes mellitus].', .omatoloski glasnik Srbije, 24(1), pp. 39- 44. Available at
• Gupta, R., Hussain, A. & Misra, A. (2020) 'Diabetes and COVID-19: evidence, current status, and unanswered resear' questions', European Journal of Clinical Nutri#on. Springer US, 74(6), pp. 864-870. DOI: 10.1038/s41430-020-0652-1
• Huang, J. et al. (2021) 'Mul#focal Electrore#nogram Can Detect !e Abnormal Re#nal -ange in Early .age of type2 DM Pa#ents wi!out Apparent Diabe#c Re#nopa!y', 2021.
• Hussain, A., Bhowmik, B. & do Vale Moreira, N. C. (2020) 'COVID-19 and diabetes: Knowledge in progress', Diabetes Resear' and Clinical Prac#ce. The au!or (s), 162, p. 108142. DOI: 10.1016/j.diabres.2020.108142.
• Imam, M. U. & Ismail, M. (2017) 'The Impact of Tradi#onal F*d and Lifestyle Behavior on Epigene#c Burden of -ronic Disease', Global -allenges, 1(8), p. 1700043. DOI: 10.1002/g'2.201700043.
• Joseph, A., Parva!y, S. & Varma, K. K. (2021) ‘Hyperinsulinemia Induced Altered Insulin Signaling Pa!way in Muscle of High Fat- and Carbohydrate-Fed Rats : Effect of Exercise', 2021.
• Kumah, E. et al. (2021) 'Review A)icle Influence of !e Model of Care on !e Outcomes of Diabetes Self- Management Educa#on Program : A Scoping Review', 2021.
• Leite, R. G. O. F. et al. (2020) 'Effec#veness of non- pharmacological strategies in !e management of type 2 diabetes in primary care: A protocol for a systema#c review and network meta-analysis', BMJ Open, 10(1), pp. 1-7. DOI: 10.1136/bmjopen-2019- 034481.
• Lever, M. et al. (2012) 'Variability of plasma and urine betaine in diabetes mellitus and its rela#onship to me!ionine load test responses : an observa#onal study', pp. 1- 8.
• Lin, X. et al. (2020) 'Global, regional, and na#onal burden and trend of diabetes in 195 countries and territories : an analysis from 1990 to 2025', Scien#fic Repo)s. Nature Publishing Group UK, (0123456789), pp. 1-11. DOI: 10.1038/s41598-020-71908-9.
• Liu, Z. et al. (2021) 'The Effect of Momordica 'aran#a in !e Treatment of Diabetes Mellitus: A Review', Evidence-based Complementary and Alterna#ve Medicine, 2021. DOI: 10.1155/2021/3796265.
• Longo, M. et al. (2020) 'Trea#ng type 2 diabetes in COVID-19 pa#ents: The poten#al benefits of injec#ve !erapies', Cardiovascular Diabetology. BioMed Central, 19(1), pp. 1- 5. DOI: 10.1186/s12933-020-01090-9.
• Mehm*d, K. & Junaid, N. (2018) ‘Prevalence of undiagnosed type 2 diabetes mellitus in Pakistan: Results of SCREEN-diabetes disease registry', Journal of !e Pakistan Medical Associa#on, 68(8), pp. 1171-1178.
• Morris, D. (2020) ',at is !e effect of COVID-19 on people wi! diabetes?', Independent Nurse, 2020(5), pp. 12-17. DOI: 10.12968/indn.2020.5.12.
• Ng, K. E. & Riard, J. P. (2020) 'The Effect of COVID-19 on Pa#ents Wi! Diabetes', diabetes, 45(11), pp. 9-12.
• Of, C. et al. (2005) 'DIABETES MELLITUS AND OTHER CATEGORIES OF DESCRIPTION OF DIABETES', 28.
• Papa!eodorou, K. et al. (2018) 'Complica#ons of Diabetes 2017', Journal of Diabetes Resear', 2018. DOI: 10.1155/2018/3086167.
• Sas, L. J. et al. (2020) 'Considera#ons for people wi! diabetes during !e Coronavirus Disease (COVID-19) pandemic', Diabetes Resear' and Clinical Prac#ce. Elsevier B.V., 166, p. 108296. DOI: 10.1016/j.diabres.2020.108296.
• Saeedi, P. et al. (2019) 'Global and regional diabetes prevalence estimates for 2019 and projec#ons for 2030 and 2045: Results from !e Interna#onal Diabetes Federa#on Diabetes Atlas, 9! edi#on', Diabetes Resear' and Clinical Prac#ce. Elsevier Ireland Ltd, 157, p. 107843. DOI: 10.1016/j.diabres.2019.107843.
• Sena, C. M. et al. (2010) ‘Diabetes mellitus: New 'allenges and innova#ve !erapies', EPMA Journal, 1(1), pp. 138-163. DOI: 10.1007/s13167-010-0010-9.
• Shan, R., Sarkar, S. & Ma)in, S. S. (2019) 'Digital heal! te'nology and mobile devices for !e management of diabetes mellitus : state of !e a)'. Diabetologia, pp. 877-887.
• Talley, N. J. et al. (2001) ‘Psy'ological distress is linked to gastrointestinal symptoms in diabetes mellitus' American Journal of Gastroenterology, 96(4), pp. 1033-1038. DOI: 10.1016/S0002-9270(00)02398-4.
• Ugwueze, C. V. et al. (2020) ‘COVID-19 and Diabetes Mellitus: The Link and Clinical Implica#ons', Dubai Diabetes and Endocrinology Journal, 26(2), pp. 69-77. DOI: 10.1159/000511354.
• Verhulst, M. J. L. et al. (2019) 'Evalua#ng all poten#al oral complica#ons of diabetes mellitus', Fron#ers in Endocrinology, 10(FEB). DOI: 10.3389/fendo.2019.00056.
• Yu, M. (2020) 'The Place of Sulfonylureas in !e Evolving Landscape of Combina#on Therapy', Diabetes Therapy. Springer Heal!care, 11(s1), pp. 23-28. DOI: 10.1007/s13300-020-00813-1.
• Zhao, R. et al. (2021) 'Nontradi#onal Therapy of Diabetes and Its Complica#ons', Journal of Diabetes Resear', 2021, pp. 1-5. DOI: 10.1155/2021/1592049.